BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23046373)

  • 1. Fibrinogen salvage during DF Thermo using Evaflux-5A plasma fractionators.
    Nakashima M; Yasui M; Ihara A
    Ther Apher Dial; 2012 Oct; 16(5):472-7. PubMed ID: 23046373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluations of double filtration plasma perfusion (DFPP) for arteriosclerosis obliterans (ASO) in maintenance hemodialysis patients].
    Chiba E
    Nihon Rinsho; 2004 May; 62 Suppl 5():603-6. PubMed ID: 15197993
    [No Abstract]   [Full Text] [Related]  

  • 3. Membranes for therapeutic apheresis.
    Nakaji S; Yamamoto T
    Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double filtration plasmapheresis in different diseases in Thailand.
    Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
    Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.
    Taniguchi M; Furukawa H; Shimamura T; Suzuki T; Yamashita K; Ota M; Todo S
    Transplantation; 2006 Jun; 81(12):1747-9. PubMed ID: 16794544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
    Vatazin AV; Zulkarnaev AB
    Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of membrane trapping in plasma fractionator on separative characteristics.
    Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
    Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of heparinization in clinical double filtration plasmapheresis.
    Hosokawa S; Oyamaguchi A; Yoshida O
    Int J Artif Organs; 1989 Aug; 12(8):544-8. PubMed ID: 2807601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryofiltration in the treatment of cryoglobulinemia and HLA antibody-incompatible transplantation.
    Sinha D; Lambie M; Krishnan N; McSorley K; Hamer R; Lowe D; Briggs D; Fletcher S; Zehnder D; Higgins RM
    Ther Apher Dial; 2012 Feb; 16(1):91-6. PubMed ID: 22248202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
    Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
    Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effective LDL removal filter for the treatment of hyperlipidemia.
    Matsuda Y; Sueoka A; Nosé Y
    Artif Organs; 1995 Feb; 19(2):129-34. PubMed ID: 7763191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous monitoring of blood volume in double filtration plasmapheresis.
    Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
    ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.
    Lin SM; Yeh JH; Lee CC; Chiu HC
    J Clin Apher; 2003; 18(2):67-70. PubMed ID: 12874818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen.
    Jensen T; Halvorsen S; Godal HC; Sandset PM; Skjønsberg OH
    Thromb Res; 2004; 113(1):51-6. PubMed ID: 15081565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.